Cover Image
市場調查報告書

胃酸過多/胃灼熱:全球臨床實驗趨勢

Burns Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 239399
出版日期 內容資訊 英文 196 Pages
訂單完成後即時交付
價格
Back to Top
胃酸過多/胃灼熱:全球臨床實驗趨勢 Burns Global Clinical Trials Review, H1, 2017
出版日期: 2017年05月31日 內容資訊: 英文 196 Pages
簡介

本報告提供胃酸過多/胃灼熱相關之臨床研究最新趨勢分析,提供您疾病·治療方法概要,及G7、E7各國的臨床實驗狀況,各地區、各階段的進行狀況,彙整有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 主要國家的臨床實驗數量; 中東/非洲地區
    • 主要國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量:胃酸過多/胃灼熱臨床實驗數量佔消化管疾病臨床實驗數量比率

各期臨床實驗數量: G7各國

G7各國的臨床實驗數量:各期

E7各國的臨床實驗數量:胃酸過多/胃灼熱臨床實驗數量佔消化管疾病臨床實驗數量比率

各期臨床實驗數量: E7各國

各期臨床實驗數量

  • 各期的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 胃酸過多/胃灼熱治療藥

有潛力的藥劑

臨床實驗簡介的基本資料

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's clinical trial report, "Burns Global Clinical Trials Review, H1, 2017" provides an overview of Burns clinical trials scenario. This report provides top line data relating to the clinical trials on Burns. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • GlobalData Clinical Trials Report Coverage 7
  • Clinical Trials by Region 8
  • Clinical Trials and Average Enrollment by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by G7 Countries: Proportion of Burns to Dermatology Clinical Trials 16
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Burns to Dermatology Clinical Trials 19
  • Clinical Trials by Phase in E7 Countries 20
  • Clinical Trials in E7 Countries by Trial Status 21
  • Clinical Trials by Phase 22
  • In Progress Trials by Phase 23
  • Clinical Trials by Trial Status 24
  • Clinical Trials by End Point Status 25
  • Subjects Recruited Over a Period of Time 26
  • Clinical Trials by Sponsor Type 27
  • Prominent Sponsors 28
  • Top Companies Participating in Burns Therapeutics Clinical Trials 29
  • Prominent Drugs 30
  • Latest Clinical Trials News on Burns 31
  • Mar 30, 2017: MediWound's NexoBrid to be Highlighted in Multiple Presentations at the Symposium on Advanced Wound Care Spring 31
  • Mar 14, 2017: MediWound's NexoBrid to be Highlighted in Presentations at the American Burn Association 49th Annual Meeting 31
  • Mar 14, 2017: MediWound's EscharEx to be Highlighted in Presentations at the American Burn Association 49th Annual Meeting 32
  • Mar 03, 2017: Cost Analysis Demonstrating Significant Health Care Savings Utilizing NexoBrid in Burn Management Published in BioMed Research International 32
  • Clinical Trial Profile Snapshots 34

Appendix 193

  • Abbreviations 193
  • Definitions 193
  • Research Methodology 194
  • Secondary Research 194
  • About GlobalData 195
  • Contact Us 195
  • Source 196

List of Tables

List of Tables

  • Burns Therapeutics, Global, Clinical Trials by Region, 2017* 8
  • Burns Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Burns Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Burns Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
  • Burns Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
  • Burns Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
  • Burns Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14
  • Burns Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 15
  • Proportion of Burns to Dermatology Clinical Trials, G7 Countries (%), 2017* 16
  • Burns Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Burns Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Burns to Dermatology Clinical Trials, E7 Countries (%), 2017* 19
  • Burns Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Burns Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Burns Therapeutics, Global, Clinical Trials by Phase, 2017* 22
  • Burns Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
  • Burns Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Burns Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Burns Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Burns Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
  • Burns Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
  • Burns Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
  • Burns Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30

List of Figures

List of Figures

  • Burns Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
  • Burns Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Burns Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Burns Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
  • Burns Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
  • Burns Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
  • Burns Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 14
  • Burns Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 15
  • Proportion of Burns to Dermatology Clinical Trials, G7 Countries (%), 2017* 16
  • Burns Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Burns Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Burns to Dermatology Clinical Trials, E7 Countries (%), 2017* 19
  • Burns Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Burns Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Burns Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
  • Burns Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23
  • Burns Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Burns Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Burns Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Burns Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
  • Burns Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
  • Burns Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
  • Burns Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
  • GlobalData Methodology 194
Back to Top